Longno, Pacita S.
HRN: 00-48-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/01/2026
08/07/2026
IV
4.5g
Q8
Cellulitis
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: